ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
8.86
-0.05 (-0.56%)
Nov 20, 2024, 4:00 PM EST - Market closed

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 6.79M EUR in the half year ending June 30, 2024, with 204.58% growth. This brings the company's revenue in the last twelve months to 9.03M, up 100.87% year-over-year. In the year 2023, ABIVAX Société Anonyme had annual revenue of 4.49M with 0.38% growth.

Revenue (ttm)
9.03M EUR
Revenue Growth
+100.87%
P/S Ratio
n/a
Revenue / Employee
148,049 EUR
Employees
61
Market Cap
547.66M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.49M17.00K0.38%
Dec 31, 20224.48M273.00K6.50%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-300.00%
Dec 31, 2019-7.00K-822.00K-100.86%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 832.70M
OrthoPediatrics 189.67M
Axogen 180.86M
Standard BioTools 155.90M
Immunome 10.13M
IGM Biosciences 2.92M
Revenue Rankings